Firsekibart is an immunoglobulin G4-lambda2 monoclonal antibody targeting human interleukin 1beta (IL-1beta). Firsekibart is promising for research of inflammation-related diseases, such as rheumatoid arthritis and inflammatory bowel disease[1].
Molecular Weight:
(145.13 kDa)
Purity:
97.387
CAS Number:
[2981430-39-9]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted